The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Marc A. De Hert

University Psychiatric Center Catholic University Leuven

UPC KUL campus Kortenberg

Leuvensesteenweg 517

3070, Kortenberg

Belgium

[email]@uc-kortenberg.be

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • University Psychiatric Center Catholic University Leuven, UPC KUL campus Kortenberg, Leuvensesteenweg 517, 3070, Kortenberg, Belgium. 2006 - 2011

References

  1. Metabolic parameters in the short- and long-term treatment of schizophrenia with sertindole or risperidone. De Hert, M., Mittoux, A., He, Y., Peuskens, J. Eur. Arch. Psychiatry. Clin. Neurosci (2011) [Pubmed]
  2. Smoking cessation for patients on clozapine. de Hert, M. Acta. Psychiatr. Scand (2011) [Pubmed]
  3. Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. De Hert, M., Vancampfort, D., Correll, C.U., Mercken, V., Peuskens, J., Sweers, K., van Winkel, R., Mitchell, A.J. Br. J. Psychiatry (2011) [Pubmed]
  4. Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice. De Hert, M., Dobbelaere, M., Sheridan, E.M., Cohen, D., Correll, C.U. Eur. Psychiatry (2011) [Pubmed]
  5. Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study. De Hert, M., Dockx, L., Bernagie, C., Peuskens, B., Sweers, K., Leucht, S., Tack, J., Van de Straete, S., Wampers, M., Peuskens, J. BMC. Gastroenterol (2011) [Pubmed]
  6. Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. De Hert, M., Correll, C.U., Cohen, D. Schizophr. Res. (2010) [Pubmed]
  7. Evaluation of the association between insight and symptoms in a large sample of patients with schizophrenia. De Hert, M.A., Simon, V., Vidovic, D., Franic, T., Wampers, M., Peuskens, J., van Winkel, R. Eur. Psychiatry (2009) [Pubmed]
  8. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). De Hert, M., Dekker, J.M., Wood, D., Kahl, K.G., Holt, R.I., Möller, H.J. Eur. Psychiatry (2009) [Pubmed]
  9. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review. De Hert, M., Schreurs, V., Sweers, K., Van Eyck, D., Hanssens, L., Sinko, S., Wampers, M., Scheen, A., Peuskens, J., van Winkel, R. Schizophr. Res. (2008) [Pubmed]
  10. A case series: evaluation of the metabolic safety of aripiprazole. De Hert, M., Hanssens, L., van Winkel, R., Wampers, M., Van Eyck, D., Scheen, A., Peuskens, J. Schizophr. Bull (2007) [Pubmed]
  11. Remission criteria for schizophrenia: evaluation in a large naturalistic cohort. De Hert, M., van Winkel, R., Wampers, M., Kane, J., van Os, J., Peuskens, J. Schizophr. Res. (2007) [Pubmed]
  12. Anticholinergic use in hospitalised schizophrenic patients in Belgium. De Hert, M., Wampers, M., van Winkel, R., Peuskens, J. Psychiatry. Res (2007) [Pubmed]
  13. Oral glucose tolerance tests in treated patients with schizophrenia. Data to support an adaptation of the proposed guidelines for monitoring of patients on second generation antipsychotics?. De Hert, M., Van Eyck, D., Hanssens, L., Peuskens, H., Thys, E., Wampers, M., Scheen, A., Peuskens, J. Eur. Psychiatry (2006) [Pubmed]
  14. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. De Hert, M.A., van Winkel, R., Van Eyck, D., Hanssens, L., Wampers, M., Scheen, A., Peuskens, J. Schizophr. Res. (2006) [Pubmed]
  15. Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study. De Hert, M., van Winkel, R., Van Eyck, D., Hanssens, L., Wampers, M., Scheen, A., Peuskens, J. Clin. Pract. Epidemiol. Ment. Health (2006) [Pubmed]
  16. Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder. De Hert, M., Kalnicka, D., van Winkel, R., Wampers, M., Hanssens, L., Van Eyck, D., Scheen, A., Peuskens, J. J. Clin. Psychiatry (2006) [Pubmed]
 
WikiGenes - Universities